Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2008

Aug 28, 2008

30339_dirs_2008-08-28_61504f45-978a-4cd8-a8a3-76118de531a7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2008-08-27

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-08-27 Common Stock S 15000 $49.0227 Disposed 224901.7069 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 792.6438 Indirect
Common Stock 27590.9314 Indirect

Footnotes

F1: This was multiple transactions on the same date with prices in the range of $48.56 to $49.24. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.